As reported by Wang et al., Lnc34a expression was significantly higher in specimens with advanced CRC than that from earlier tumors, suggesting that Lnc34a expression may be a potential biomarker for advanced stages [83]. This evidence concerns the gene MIR34AHG and colorectal carcinoma.